Dexcom (DXCM) net income: $836M
Dexcom reported a net income of $836M for the year ended Dec 31, 2025, up 45.1% from $576M a year earlier.
From Dexcom's filings with the SEC · Read the filing · DXCM stock page
Dexcom net income by year
#424 of 3,748 US companies by net income · See the full ranking
| Year ended | Net income | Change |
|---|---|---|
| Dec 31, 2025 | $836M | +45% |
| Dec 31, 2024 | $576M | +6% |
| Dec 31, 2023 | $542M | +59% |
| Dec 31, 2022 | $341M | +57% |
| Dec 31, 2021 | $217M | – |
Net income of similar companies
Companies in the same industry as Dexcom, by SEC industry code, with the closest net income. Each name opens the same page for that company.
| Company | Net income, latest year | Year ended |
|---|---|---|
| Becton Dickinson | $1.7B | Sep 30, 2025 |
| Solventum | $1.6B | Dec 31, 2025 |
| Resmed | $1.5B | Jun 30, 2026 |
| Dexcom | $836M | Dec 31, 2025 |
| Globus Medical | $538M | Dec 31, 2025 |
| West Pharmaceutical Services | $494M | Dec 31, 2025 |
| Insulet | $247M | Dec 31, 2025 |
Questions and answers
What is Dexcom's net income?
Dexcom reported a net income of $836M for the year ended Dec 31, 2025, up 45.1% from $576M a year earlier.
Numbers as reported in Dexcom's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology